Cytotoxicity of several chemotherapeutic agents in a human pancreatic cancer cell line (Colo-357)

Cancer Treat Rep. 1984 Feb;68(2):429-30.

Abstract

Seven commonly available chemotherapeutic drugs were used to determine the concentration and time of exposure necessary to kill the newly available human pancreatic cancer cell line, Colo-357. The exposure periods were 2, 6, 12, and 24 hours. The most active drugs were methotrexate, mitomycin, and doxorubicin, each with an ID50 less than 0.1 microM for both a 12- and a 24-hour exposure. Cisplatin was intermediate, with an ID50 of approximately 0.7 microM at 12 and 24 hours. 5-FU, carmustine, and streptozocin were the least effective agents, with ID50 values greater than 50 microM after a 12-hour exposure and greater than 25 microM after a 24-hour exposure.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Cell Line
  • Cell Survival / drug effects*
  • Doxorubicin / therapeutic use
  • Drug Evaluation
  • Humans
  • Methotrexate / therapeutic use
  • Mitomycins / therapeutic use
  • Pancreatic Neoplasms / drug therapy*
  • Time Factors

Substances

  • Antineoplastic Agents
  • Mitomycins
  • Doxorubicin
  • Methotrexate